Surgical Science Sweden AB (publ) (STO:SUS)
Sweden · Delayed Price · Currency is SEK 30.84
+0.64 (2.12%)
Jul 24, 2026, 5:29 PM CET
STO:SUS Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 977.13 | 992.34 | 884.09 | 882.85 | 802.54 | 366.78 | |
Revenue Growth (YoY) | 3.23% | 12.25% | 0.14% | 10.01% | 118.81% | 249.98% |
Cost of Revenue | 337.09 | 334.67 | 286.19 | 269.97 | 271.02 | 100.84 |
Gross Profit | 640.05 | 657.68 | 597.9 | 612.88 | 531.52 | 265.94 |
Selling, General & Admin | 297.11 | 326.6 | 252.38 | 240.02 | 201.88 | 145.96 |
Depreciation & Amortization Expenses | 20.16 | - | - | - | - | - |
Research & Development | 224.87 | 222.11 | 196.11 | 181.57 | 172.79 | 65.71 |
Other Operating Expenses | 50.25 | 40.09 | 5.09 | 2.14 | -5.68 | -2.25 |
Total Operating Expenses | 592.39 | 588.79 | 453.58 | 423.73 | 368.98 | 209.42 |
Operating Income | 67.82 | 68.88 | 144.32 | 189.15 | 162.54 | 56.52 |
Interest Income | - | 40.37 | 25.29 | 79.77 | 65.12 | 32.23 |
Interest Expense | - | -9.11 | -11.52 | -0.66 | -19.48 | -22.95 |
Other Non-Operating Income (Expense) | 7.74 | - | - | - | - | - |
Total Non-Operating Income (Expense) | 7.74 | 31.26 | 13.77 | 79.11 | 45.64 | 9.28 |
Pretax Income | 75.56 | 100.14 | 158.09 | 268.26 | 208.17 | 65.8 |
Provision for Income Taxes | 23.35 | 33.32 | 26.45 | 34.29 | 20.2 | -20.44 |
Net Income | 52.21 | 66.82 | 131.65 | 233.97 | 187.97 | 86.25 |
Net Income to Common | 52.21 | 66.82 | 131.65 | 233.97 | 187.97 | 86.25 |
Net Income Growth | -63.00% | -49.24% | -43.73% | 24.47% | 117.95% | 452.66% |
Shares Outstanding (Basic) | 51 | 51 | 51 | 51 | 51 | 42 |
Shares Outstanding (Diluted) | 51 | 51 | 51 | 51 | 51 | 43 |
Shares Change (YoY) | - | - | 0.17% | 0.05% | 19.32% | 24.14% |
EPS (Basic) | 1.03 | 1.31 | 2.58 | 4.59 | 3.70 | 2.03 |
EPS (Diluted) | 1.03 | 1.31 | 2.58 | 4.59 | 3.69 | 2.02 |
EPS Growth | -62.68% | -49.23% | -43.79% | 24.39% | 82.67% | 348.89% |
Free Cash Flow | 131.16 | 68.12 | 131.12 | 227.84 | 120.14 | 35.21 |
Free Cash Flow Growth | 35.36% | -48.05% | -42.45% | 89.65% | 241.18% | 54.26% |
Free Cash Flow Per Share | 2.57 | 1.33 | 2.57 | 4.47 | 2.36 | 0.83 |
Gross Margin | 65.50% | 66.27% | 67.63% | 69.42% | 66.23% | 72.51% |
Operating Margin | 6.94% | 6.94% | 16.32% | 21.43% | 20.25% | 15.41% |
Profit Margin | 5.34% | 6.73% | 14.89% | 26.50% | 23.42% | 23.52% |
FCF Margin | 13.42% | 6.86% | 14.83% | 25.81% | 14.97% | 9.60% |
EBITDA | 67.82 | 152.25 | 204.83 | 244.77 | 214.12 | 90.04 |
EBITDA Margin | 6.94% | 15.34% | 23.17% | 27.72% | 26.68% | 24.55% |
EBIT | 67.82 | 68.88 | 144.32 | 189.15 | 162.54 | 56.52 |
EBIT Margin | 6.94% | 6.94% | 16.32% | 21.43% | 20.25% | 15.41% |
Effective Tax Rate | 30.90% | 33.27% | 16.73% | 12.78% | 9.70% | -31.07% |